Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development
Abstract Coronavirus disease 2019 (COVID‐19) global pandemic is caused by severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral infection, which can lead to pneumonia, lung injury, and death in susceptible populations. Understanding viral dynamics of SARS‐CoV‐2 is critical for developme...
Guardado en:
Autores principales: | Youfang Cao, Wei Gao, Luzelena Caro, Julie A. Stone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1ae0f6eb4842422aa0440c30df295216 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu T, et al.
Publicado: (2021) -
Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
por: Yao J, et al.
Publicado: (2021) -
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
por: Russell M. Petrak, et al.
Publicado: (2021) -
Melatonergic drugs in development
por: Carocci A, et al.
Publicado: (2014) -
Role of IFN and Complements System: Innate Immunity in SARS-CoV-2
por: Shibabaw T, et al.
Publicado: (2020)